About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...
Ketamine also has come under increasing scrutiny as a treatment recently, with studies suggesting that for some patients it ...
El Mundo on MSN22h
US approves a new painkiller with less risk of addiction than opioids and equally potentThe suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
Patients and family members accuse Yale and YNHH of failing to relieve pain for ICU patients. The lawsuit comes half a year ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
A team of researchers at the Medical University of South Carolina has discovered that a commonly used drug, N-acetylcysteine (NAC), could help reduce pain after surgery.
Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...
Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results